Screener
Whitehawk Therapeutics WHWK Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Whitehawk Therapeutics’s reported figures.
The source filing: Whitehawk Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:25 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212075
FAQ
- What is Whitehawk Therapeutics's free cash flow?
- Whitehawk Therapeutics (WHWK) reported free cash flow of -$22.21M in Q1 2026.
- How has Whitehawk Therapeutics's free cash flow changed year-over-year?
- Whitehawk Therapeutics's free cash flow decreased by 78.9% year-over-year, from -$12.42M to -$22.21M.
- What is the long-term trend for Whitehawk Therapeutics's free cash flow?
- Over 3 years (2021 to 2025), Whitehawk Therapeutics's free cash flow has grown at a 63.4% compound annual growth rate (CAGR), from -$22.47M to -$97.99M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Whitehawk Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude